[
  {
    "uuid": "fd9b0fc6c131fb1290e5031fe1cf55a9dda481ab",
    "url": "https://hindi.etnownews.com/markets/crorepati-stock-uno-minda-share-price-multibagger-return-article-152335545",
    "ord_in_thread": 0,
    "author": "@EtNowSwadesh",
    "published": "2025-07-24T03:29:00Z",
    "title": "Crorepati Stock: कभी 5 रुपये से कम था, अब 17000% ऊपर निकला शेयर का भाव; पैसा लगाने वाले बने करोड़पति - मार्केट | ET Now Swadesh",
    "text": "कभी 5 रुपये से कम था; अब आसमान पर पहुंचा शेयर का भाव, पैसा लगाने वाले बने करोड़पति\nCrorepati Stock: मल्टीबैगर स्टॉक UNO Minda के शेयरों ने तमाम उतार-चढव के बीच निवेशकों को मोटी कमाई कराई है। इस शेयर ने लिस्टिंग के बाद से अपने शानदार रिटर्न से निवेशकों की पूंजी कई गुना बढ़ा दी है। इस स्टॉक ने 17,000 प्रतिशत से अधिक का मल्टीबैगर रिटर्न दिया है। क्या ये स्टॉक आपके पोर्टफोलियो का हिस्सा है?\nAuthored by:\nET Now DigitalUpdated Jul 24, 2025 08:59 IST\nCrorepati Stock: निवेशकों को करोड़पति बनाने वाला शेयर\nआर्टिकल हाइलाइट्स\n- मल्टीबैगर स्टॉक UNO Minda के शेयरों ने तमाम उतार-चढव के बीच निवेशकों को मोटी कमाई कराई है।\n- इस शेयर ने लिस्टिंग के बाद से अपने शानदार रिटर्न से निवेशकों की पूंजी कई गुना बढ़ा दी है।\n- इस स्टॉक ने 17,000 प्रतिशत से अधिक का मल्टीबैगर रिटर्न दिया है। क्या ये स्टॉक आपके पोर्टफोलियो का हिस्सा है?\nCrorepati Stock, मल्टीबैगर स्टॉक: भारतीय शेयर बाजार में हाल ही में काफी उतार-चढ़ाव देखने को मिला है, जिसकी वजह राष्ट्रपति डोनाल्ड ट्रंप द्वारा लगाए गए अमेरिकी टैरिफ, भारत-पाकिस्तान तनाव और इज़राइल-ईरान संघर्ष जैसे भू-राजनीतिक तनाव थे। इन घटनाओं ने निवेशकों के लिए एक चुनौतीपूर्ण माहौल पैदा कर दिया था, हालाँकि अब बाज़ार उस उथल-पुथल से उबर चुका है। ग्लोबल मार्केट में मिले-जुले कारोबार के बीच घरेलू इक्विटी सूचकांक सेंसेक्स और NIFTY50 बुधवार को हरे निशान पर बंद हुए।\nइस तमाम उतार-चढ़ाव के बीच एक स्टॉक ऐसा है, जो अस्थिरता को मात देने और निवेशकों को लगातार प्रॉफिट देने में कामयाब रहा है। इस स्टॉक का नाम UNO Minda। इस स्टॉक ने निवेशकों को करोड़पति बना दिया है।\nनिवेशकों को करोड़पति बनाने वाला शेयर\nयूएनओ मिंडा का शेयर करीब 12 साल पहले अगस्त 2013 में ₹4.50 पर था। अब\nBSEपर ये मल्टीबैगर स्टॉक ₹1071 के आसपास कारोबार कर रहा है। बुधवार, 23 जुलाई को स्टॉक सपाट कारोबार करते हुए हरे निशान में 1071.35 रुपये पर बंद हुआ।इस स्टॉक ने 2013 में इस लेवल से 17,000 प्रतिशत से अधिक का मल्टीबैगर रिटर्न दिया है। जिन निवेशकों ने इस लेवल पर स्टॉक खरीदा होता और अब तक उसे बेचा न होता तो 12 साल पहले इस शेयर में किया गया ₹1 लाख का निवेश अब तक 1.70 करोड़ से अधिक हो गया होता।\nबताते चलें कि इस अवधि के दौरान कंपनी ने 1:1 और 2:1 अनुपात में बोनस शेयर भी जरी किए हैं। फिलहाल, रिटर्न को कैकुलेट करते समय बोनस के बाद के लाभ शामिल नहीं किए गए हैं।\nकैसी है शेयरों की परफॉर्मेंस\nपिछले एक साल में यह शेयर अस्थिर रहा है। इस मल्टीबैगर स्टॉक में एक महीने में सिर्फ 1.33 प्रतिशत की बढ़ोतरी हुई है, जबकि एक साल में इसमें 6 प्रतिशत से ज़्यादा की तेजी आई है। साल-दर-साल (YTD) प्रदर्शन के लिहाज़ से, यह शेयर 2025 की शुरुआत से 1.02 प्रतिशत से ज़्यादा बढ़कर ₹1,071 से स्तर पर पहुँच गया है।\nकंपनी को मिली बड़ी कामयाबी\nहाल ही में यूनो मिंडा लिमिटेड को एक बड़ी कामयाबी मिली है। कंपनी ने अपनी स्वामित्व वाली सहायक कंपनी अर्थात मिंडा इंडस्ट्रीज वियतनाम कंपनी लिमिटेड के माध्यम से वियतनाम में फ्रिवो वियतनाम कंपनी लिमिटेड से ई-ड्राइव्स कमर्शियल असेट्स का अधिग्रहण पूरा कर लिया है।\nUNO Minda Q4 Results 2025\nUno Minda ने मार्च तिमाही के लिए शुद्ध लाभ में साल-दर-साल 7.5% कमी रिपोर्ट की। ये घटकर ₹266 करोड़ रह गया, जबकि पिछले साल इसी तिमाही में यह ₹287.9 करोड़ था। हालांकि,रेवेन्यू में साल-दर-साल 19.4% की वृद्धि देखी गई।\nDisclaimer: ये आर्टिकल सिर्फ जानकारी के लिए है और इसे किसी भी तरह से इंवेस्टमेंट सलाह के रूप में नहीं माना जाना चाहिए। ET NOW Swadesh अपने पाठकों और दर्शकों को पैसों से जुड़ा कोई भी फैसला लेने से पहले अपने वित्तीय सलाहकारों से सलाह लेने का सुझाव देता है।\nपढ़ें बिजनेस न्यूज़, पर्सनल फाइनेंस ,अन्य देश से जुड़ी ब्रेकिंग न्यूज़ और पाएं स्टॉक मार्केट के अपडेट हिंदी में और देखें छोटी बड़ी बिजनेस और शेयर बाज़ार से संबंधित सभी न्यूज़ ET Now Swadesh Live TV पर।\nआर्टिकल की समाप्ति",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "hindi",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Social Issue",
      "Human Interest"
    ],
    "topics": [
      "Economy, Business and Finance->business strategy and marketing",
      "Economy, Business and Finance->financial service",
      "Social Issue->poverty",
      "Social Issue->social condition",
      "Human Interest->record and achievement"
    ],
    "ai_allow": false,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "internal_images": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "top_news": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-07-24T07:48:25.500+03:00",
    "updated": "2025-07-24T07:53:02.000+03:00"
  },
  {
    "uuid": "b8fda9c118eb610920eee9ea290cb05eb5af6aa8",
    "url": "https://thepaleodiet.com/sipping-smart-the-impact-of-alcohol-on-inflammation",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Andrea Dehnke",
    "published": "2024-12-19T20:52:00Z",
    "title": "Sipping Smart: The Impact of Alcohol on Inflammation",
    "text": "The general consensus is that the impact of alcohol is largely negative, but we’re all human, and it can be nice to drink in social settings and around the holidays. Does that mean alcoholic drinks comply with The Paleo Diet®? No, but like many other things in life, moderation is key. We like the 85/15 principle, meaning your diet is comprised of 85% healthy Paleo choices and 15% mindful indulgences.\nBut first, there is an important distinction to be made between light drinking and binge drinking. A binge is classified as five or more drinks for men and four or more drinks for women over a two-hour period. Binge drinking is significantly worse for you than just an occasional beer or a glass of wine at dinner, causing a cascade of inflammatory signals and even organ damage. 1\nThe Sweet Spot for Balancing Alcohol and Health The impact of alcohol consumption on inflammation is an interesting one. While we would assume that alcohol always causes inflammation, it’s not that simple. The relationship between alcohol and inflammation is a J-shaped curve, meaning that a low level of alcohol consumption can actually decrease inflammation, but high levels are very damaging. 1 The inflammation curve follows the same shape as the mortality curve below. 2\nComparison of All-Cause Mortality in Relation to Number of Alcoholic Drinks Consumed 3 If you’re wondering how often you can drink—as long as you stay under the limits—women can have one daily drink without causing damage, while men can have two drinks in a day. 4 One drink is equivalent to 5 oz. of wine at 12% alcohol by volume (ABV), 12 oz. of beer (5% ABV), and 1.5 oz. of liquor (40% ABV).\nWhile this falls outside of The Paleo Diet’s guidelines, low-level of alcohol consumption is not damaging to your health. As the previous graph shows, the most positive effect is seen at 0.5 alcoholic drinks a day. With light drinking, factors like type of alcohol, age, sex, and medical conditions play a role in if inflammation develops or not. But heavy drinking is always damaging, regardless of other factors.\nWhy Wine Outshines Beer and Liquor You may have heard that a glass of wine per day is good for you, and that’s partly true. Red wine contains compounds called polyphenols. Many have antioxidant properties, protecting your cells from the damaging molecules produced during the breakdown of alcohol. But you know what else has polyphenols and is way healthier? Fruits, veggies, and chocolate.\nAmong the other types of alcohol, beer has no effect on inflammation in low quantities, and liquor increases inflammation regardless of the amount consumed. 4 So while wine may not be inherently healthy, it is the better choice compared to beer and liquor.\nKeep in mind that most wines are laden with preservatives like sulfites, which are not very good for you. Consider seeking out organic wines that do not include these preservatives.\nThe Impact of Alcohol on Chronic Conditions Interestingly, people with a genetic predisposition for cardiovascular disease will experience the most positive effects from red wine out of any other group. 5 This is because those handy polyphenols can help you rebalance your cholesterol and lower systemic inflammation, so if you’re already healthy, the polyphenols won’t do as much for you.\nIf you are clinically obese or have any other chronic illness, the potential for alcohol to damage your organs, weaken your immune system, and worsen your existing conditions is significantly higher. 1\nWhy Age and Gender Matter When You Drink Women metabolize alcohol less efficiently than men, even when they weigh the same. Studies have shown that women experience more inflammation and cognitive disturbances at lower alcohol levels compared to men. The exact reason is unknown, but it’s supported by numerous studies. 4, 6\nAs we age, our bodies become less capable of metabolizing alcohol, resulting in a higher blood alcohol concentration. 1, 4 Other factors like compromised organ function, medications, and medical conditions can make alcohol consumption more dangerous. 7, 8\nWhat Happens When You Overdo It Binge drinking leads to high blood alcohol, meaning that alcohol circulates in your body and permeates nearly every tissue. 1 Our bodies are usually pretty good at protecting us from toxins, but when you binge drink, your body can’t keep up. Our cells have something called glutathione (GSH), an organic compound that works as an antioxidant, 1 protecting cells from a number of damaging particles.\nAlcohol’s breakdown process creates a toxic byproduct called acetaldehyde 9 that is quickly converted to less damaging molecules. When you drink a lot of alcohol, your body breaks down more of the alcohol into acetaldehyde, and your cells try to protect themselves with the GSH, but its reserves are depleted. That’s when the acetaldehyde begins damaging your cells. 1\nWhile alcohol can damage your stomach and esophagus as well by raising acidity levels, acetaldehyde is mostly created in the intestine 1 and liver. 9 Excess acetaldehyde attacks your gut microbiome, killing off protective cells and damaging the lining. A damaged lining allows toxins to enter the bloodstream, where they can wreak havoc on your organs. 1\nYour immune system recognizes those toxins and goes into overdrive trying to get rid of them, causing immune exhaustion and systemic inflammation. You’ll also experience localized inflammation in the liver, pancreas, brain, and kidneys. 9\nEverything in Moderation If you want to have a drink or two sometimes, that’s totally fine and may even be beneficial (especially if you like red wine). But binge drinking should be avoided at all costs since even one episode of binge drinking can allow toxins into the bloodstream. 6 The safest way for you to mitigate the negative impact of alcohol is to drink a glass or two of organic red wine, slowly, with food.\nYou don’t need to exclusively drink red wine to experience those inflammation-improving effects—but can opt for a functional mocktail instead. Our Old-Fashioned Mocktail is made with tart cherry juice, which contains inflammation-reducing polyphenols. Explore our full collection of non-alcoholic beverages at the link below.\nNon-Alcoholic Beverages References Molina PE, Nelson S. Binge Drinking’s Effects on the Body. Alcohol Res. 2018;39(1):99-109. PMID: 30557153; PMCID: PMC6104963. https://pubmed.ncbi.nlm.nih.gov/30557153/ Albert, M. A., Glynn, R. J., & Ridker, P. M. (2003). Alcohol consumption and plasma concentration of C-reactive protein. Circulation, 107(3), 443–447. https://doi.org/10.1161/01.cir. 45669.16499.ec Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006 Dec 11-25;166(22):2437-45. doi: 10.1001/archinte.166.22.2437. PMID: 17159008. https://pubmed.ncbi.nlm.nih.gov/17159008/ Li, X., Hur, J., Cao, Y., Song, M., Smith-Warner, S. A., Liang, L., Mukamal, K. J., Rimm, E. B., & Giovannucci, E. L. (2023). Moderate alcohol consumption, types of beverages and drinking pattern with cardiometabolic biomarkers in three cohorts of US men and women. European Journal of Epidemiology, 38(11), 1185–1196. https://pmc.ncbi.nlm.nih.gov/articles/PMC10924636/ Maraldi, C., Volpato, S., Kritchevsky, S. B., Cesari, M., Andresen, E., Leeuwenburgh, C., Harris, T. B., Newman, A. B., Kanaya, A., Johnson, K. C., Rodondi, N., & Pahor, M. (2006). Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events. Archives of Internal Medicine, 166(14), 1490. https://doi.org/10.1001/archinte.166.14.1490 Orio, L., Antón, M., Rodríguez‐Rojo, I. C., Correas, Á., García‐Bueno, B., Corral, M., de Fonseca, F. R., García‐Moreno, L. M., Maestú, F., & Cadaveira, F. (2017). Young alcohol binge drinkers have elevated blood endotoxin, peripheral inflammation and low cortisol levels: Neuropsychological correlations in women. Addiction Biology, 23(5), 1130–1144. https://doi.org/10.1111/adb.12543 Stankevic, E., Israelsen, M., Juel, H. B., Madsen, A. L., Ängquist, L., Aldiss, P. S., Torp, N., Johansen, S., Hansen, C. D., Hansen, J. K., Thorhauge, K. H., Lindvig, K. P., Madsen, B. S., Sulek, K., Legido‐Quigley, C., Thiele, M. S., Krag, A., & Hansen, T. (2023). Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers. Liver International, 43(12), 2680–2691. https://doi.org/10.1111/liv.15692 Alcohol and age: A risky combination. Harvard Health. (2018, January 27). https://www.health.harvard.edu/diseases-and-conditions/alcohol-and-age-a-risky-combination U.S. Department of Health and Human Services. (2022, May). Alcohol metabolism. National Institute on Alcohol Abuse and Alcoholism. https://www.niaaa.nih.gov/publications/alcohol-metabolism",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Social Issue"
    ],
    "topics": [
      "Health->medical condition",
      "Health->health treatment and procedure",
      "Social Issue->social condition",
      "Social Issue->addiction"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "webz_reporter": false,
    "external_links": [
      "https://pubmed.ncbi.nlm.nih.gov/17159008/",
      "https://doi.org/10.1001/archinte.166.14.1490",
      "https://pubmed.ncbi.nlm.nih.gov/30557153/",
      "https://doi.org/10.1111/liv.15692",
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC10924636/",
      "https://www.niaaa.nih.gov/publications/alcohol-metabolism",
      "https://doi.org/10.1111/adb.12543",
      "https://doi.org/10.1161/01.cir.0000045669.16499.ec",
      "https://www.health.harvard.edu/diseases-and-conditions/alcohol-and-age-a-risky-combination",
      "https://www.pmc.ncbi.nlm.nih.gov/articles/PMC10924636/",
      "https://pubmed.ncbi.nlm.nih.gov/30557153",
      "https://www.pubmed.ncbi.nlm.nih.gov/30557153/",
      "https://www.doi.org/10.1111/adb.12543",
      "https://www.pubmed.ncbi.nlm.nih.gov/17159008/",
      "https://niaaa.nih.gov/publications/alcohol-metabolism",
      "https://www.doi.org/10.1161/01.cir.0000045669.16499.ec",
      "https://www.doi.org/10.1111/liv.15692",
      "https://www.doi.org/10.1001/archinte.166.14.1490",
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC10924636",
      "https://health.harvard.edu/diseases-and-conditions/alcohol-and-age-a-risky-combination",
      "https://pubmed.ncbi.nlm.nih.gov/17159008"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-12-20T02:48:58.201+02:00",
    "updated": "2024-12-20T02:48:58.201+02:00"
  },
  {
    "uuid": "37d77cb5af3d188ed5206b34c8b95aa32cb69e96",
    "url": "https://www.channelnewsasia.com/business/sam-altmans-rebranded-worldcoin-ramps-up-iris-scanning-crypto-project-4686406",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "CNA",
    "published": "2024-10-17T21:56:00Z",
    "title": "Sam Altman's rebranded Worldcoin ramps up iris-scanning crypto project - CNA",
    "text": "Best News Website or Mobile Service WAN-IFRA Digital Media Awards Worldwide 2022 Best News Website or Mobile Service Digital Media Awards Worldwide 2022\nSign In\nAccount My Feed\nSearch Edition Menu Edition: Singapore Indonesia Asia US/UK Edition: Singapore Indonesia Asia US/UK Navigate to other CNA editions here.\nHamburger Menu Close Latest News Top Stories Asia East Asia Singapore World Commentary CNA Explains Sustainability Business Sport Insider TODAY Big Read Up Close Ground Up Voices Adulting Mental Health Matters Learning Minds Watch Live TV News Reports Documentaries & Shows TV Schedule Listen CNA938 Live Podcasts Radio Schedule Special Reports Singapore Parliament Mental Health Interactives Lifestyle Entertainment Women Wellness Living Style & Beauty Dining Travel Luxury Experiences Obsessions People Remarkable Living Sustainability Newsletters CNA Eyewitness Send us a news tip Events & Partnerships Branded Content Business Blueprint Health Matters The Asian Traveller Brand Studio Learning Minds Weather Edition: Singapore Indonesia Asia US/UK Navigate to other CNA editions here.\nClose Close Latest News Top Stories Asia East Asia Singapore World Commentary CNA Explains Sustainability Business Sport Insider TODAY Big Read Up Close Ground Up Voices Adulting Mental Health Matters Learning Minds Watch Live TV News Reports Documentaries & Shows TV Schedule Listen CNA938 Live Podcasts Radio Schedule Special Reports Singapore Parliament Mental Health Interactives Lifestyle Entertainment Women Wellness Living Style & Beauty Dining Travel Luxury Experiences Obsessions People Remarkable Living Sustainability Newsletters CNA Eyewitness Send us a news tip Events & Partnerships Branded Content Business Blueprint Health Matters The Asian Traveller Brand Studio Learning Minds Weather Edition: Singapore Indonesia Asia US/UK Navigate to other CNA editions here.\nSearch Trending Topics CNA Explains China Malaysia artificial intelligence Israel-Hamas war Snap Insight Indonesia Wellness Follow CNA Follow our news Facebook Twitter Youtube LinkedIn RSS\nRecent Searches Trending Topics CNA Explains China Malaysia artificial intelligence Israel-Hamas war Snap Insight Indonesia Wellness Main navigation Top Stories Latest News Asia East Asia Singapore Commentary Insider TODAY Lifestyle Watch Listen + All Sections Business\nSam Altman's rebranded Worldcoin ramps up iris-scanning crypto project Bookmark Bookmark Share WhatsApp Telegram Facebook Twitter Email LinkedIn Close Close Latest News Top Stories Asia East Asia Singapore World Commentary CNA Explains Sustainability Business Sport Insider TODAY Big Read Up Close Ground Up Voices Adulting Mental Health Matters Learning Minds Watch Live TV News Reports Documentaries & Shows TV Schedule Listen CNA938 Live Podcasts Radio Schedule Special Reports Singapore Parliament Mental Health Interactives Lifestyle Entertainment Women Wellness Living Style & Beauty Dining Travel Luxury Experiences Obsessions People Remarkable Living Sustainability Newsletters CNA Eyewitness Send us a news tip Events & Partnerships Branded Content Business Blueprint Health Matters The Asian Traveller Brand Studio Learning Minds Weather Edition: Singapore Indonesia Asia US/UK Navigate to other CNA editions here.\nSearch Trending Topics CNA Explains China Malaysia artificial intelligence Israel-Hamas war Snap Insight Indonesia Wellness Follow CNA Follow our news Facebook Twitter Youtube LinkedIn RSS\nRecent Searches Trending Topics CNA Explains China Malaysia artificial intelligence Israel-Hamas war Snap Insight Indonesia Wellness Advertisement Advertisement Business\nSam Altman's rebranded Worldcoin ramps up iris-scanning crypto project\nSam Altman, CEO of OpenAI, attends the Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S. November 16, 2023. REUTERS/Carlos Barria/File Photo\n18 Oct 2024 05:56AM Bookmark Bookmark Share WhatsApp Telegram Facebook Twitter Email LinkedIn SAN FRANCISCO : - Worldcoin, a cryptocurrency project founded by OpenAI CEO Sam Altman, said on Thursday it was rebranding to World Network and was ramping up efforts to scan every human's iris using its \"orb\" devices.\nIts core offering is its World ID, which the company describes as a \"digital passport\" to prove that its holder is a real human and tell the difference with AI chatbots online.\nWorld Network, which is facing scrutiny over its data collection, introduced a new version of its orb iris-scanning device at an event in San Francisco on Thursday, which it said features 5G connectivity and enhanced privacy and security features.\nIt also unveiled a slew of new ways to make it easier to access the orb, such as purpose-built retail locations and a partnership with Latin American delivery service Rappi to bring orbs to people.\nTo get a World ID, a customer signs up to do an in-person iris scan using World Network's \"orb\", a silver ball approximately the size of a bowling ball.\nOnce the orb's iris scan verifies the person is a real human, it creates a World ID. As an enticement, those who sign up in certain countries receive a cryptocurrency token called WLD.\nThe company behind World Network is San Francisco and Erlangen, Germany-based Tools for Humanity. Since the project launched in July 2023, over 6.9 million people have signed up to have their irises scanned, according to the company.\nPrivacy campaigners have criticized the project over the collection, storage and use of personal data.\nEarlier this year, Spain and Portugal issued temporary bans, and Argentina and Britain said they would examine World Network.\nSource: Reuters Sign up for our newsletters Get our pick of top stories and thought-provoking articles in your inbox\nSubscribe here Get the CNA app Stay updated with notifications for breaking news and our best stories\nDownload here Get WhatsApp alerts\nJoin our channel for the top reads for the day on your preferred chat app\nJoin here Advertisement Also worth reading Content is loading... Advertisement",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology",
      "Business and Market Analysis"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [
      "https://cna.asia/whatsapp",
      "https://www.cna.asia/whatsapp"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-10-18T01:16:39.715+03:00",
    "updated": "2024-10-18T07:36:32.148+03:00"
  },
  {
    "uuid": "6dbed72688b2df35b8115bf0f45f0b992abed308",
    "url": "https://heraldodemexico.com.mx/elecciones/2024/6/6/ruben-moreira-inversionistas-les-aterra-que-morena-no-tenga-contrapesos-en-el-congreso-610266.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Jorge Almaquio García y Víctor Ortega",
    "published": "2024-06-06T21:41:00Z",
    "title": "Rubén Moreira: a inversionistas les aterra que Morena no tenga contrapesos en el Congreso | El Heraldo de México",
    "text": "El PRI en la Cámara de Diputados aseguró que hay [ preocupación por parte de los inversionistas](https://heraldodemexico.com.mx/economia/2024/6/4/triunfo-de-claudia-sheinbaum-no-debilitara-el-super-peso-mexicano-seguira-fuerte-hasta-el-2025-608454.html) después de los resultados de las elecciones del pasado 2 de junio, ya que, para la próxima legislatura, desaparecerían los contrapesos y no habrá forma de parar las reformas constitucionales que presentó recientemente el Ejecutivo Federal, El coordinador de parlamentario, [Rubén Moreira Valdez](https://heraldodemexico.com.mx/edicion-impresa/2024/4/21/morena-comete-un-grave-error-en-su-iniciativa-para-crear-el-fondo-de-pensiones-para-el-bienestar-asegura-ruben-moreira-596049.html), afirmó que esto provoca la caída del “súper peso” y de los mercados en la Bolsa Mexicana de Valores (BMV), sumado al reconocimiento de que hay un alto endeudamiento. Acompañado por el economista Mario Di Costanzo, en el programa “Con Peras, Manzanas y Naranjas”, el coordinador parlamentario del PRI realizó un análisis de la respuesta del titular de la Secretaría de Hacienda, Rogelio Ramírez de la O, sobre el nerviosismo financiero. Sigue leyendo: [Morena: Plan C iniciará con la próxima Legislatura en Cámara de Diputados](https://heraldodemexico.com.mx/elecciones/2024/6/6/morena-plan-iniciara-con-la-proxima-legislatura-en-camara-de-diputados-610206.html) [24 para 2024: propuestas para impulsar las fortalezas de México como líder global](https://heraldodemexico.com.mx/opinion/2024/6/6/24-para-2024-propuestas-para-impulsar-las-fortalezas-de-mexico-como-lider-global-610033.html) Asegura que no hay recursos para aumentar los programas sociales Advirtió que los inversionistas que se asustaron esta semana con los resultados electorales y sacaron dólares, también saben que en los Precriterios Económicos 2025 de Hacienda ya se señala que el próximo año, no se contará con el dinero suficiente para aumentar los programas sociales y tampoco para obra pública nueva. Criticó la alianza de los grandes inversionistas con el gobierno, que ahora se asustan por lo que dijo la Secretaria de Gobernación, Luisa María Alcalde respecto a que [ las dos terceras partes del Congreso las tiene Morena](https://heraldodemexico.com.mx/elecciones/2024/6/6/morena-plan-iniciara-con-la-proxima-legislatura-en-camara-de-diputados-610206.html), por la posibilidad que iniciativas atractivas, pero que pueden llevar al país a la quiebra, sean votadas. Entre las propuestas del Ejecutivo que generan temor, Moreira Valdés mencionó que la elección de los ministros de la Corte se realice por tómbola, que ya no habrá órganos autónomos, no habrá Amparo, no habrá minorías en las cámaras. Estiman aumento de la deuda De manera previa, en sus redes sociales, Moreira Valdez anotó que el resultado de las elecciones tiene aterrados a los inversionistas y con razón, no solo por la incertidumbre en la estabilidad económica y financiera del país, sino porque Morena cuenta también con los votos en las cámaras para sacar adelante las reformas que desmantelan el Estado Constitucional de derecho. Mario Di Costanzo, analista económico recordó que el déficit ha ido creciendo en este sexenio, el cual suma en esta Administración 5.3 billones de pesos, con lo que se muestra que no hay estabilidad financiera. Sobre los precriterios señala que la deuda aumentará 1.1 billones de pesos, cerrando 2025 con una deuda total de 18.1 billones de pesos. El especialista enfatizó que aumentará el pago de intereses de la deuda, mientras se reduce el gasto programable, indicios de que habrá menos para carreteras, salud y educación, porque ya no alcanza con lo que hay, y eso, dijo, es lo que ven los inversionistas.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Politics",
      "Business and Market Analysis"
    ],
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-06-07T01:12:45.129+03:00",
    "updated": "2024-06-07T01:12:45.129+03:00"
  },
  {
    "uuid": "bfd87ed932e1ab0d313482bda5001420680b96f3",
    "url": "https://vnexplorer.net/el-sepe-publica-ofertas-de-empleo-indefinido-para-personal-de-limpieza-sueldo-de-1-800-euros-s706159.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "VNExplorer",
    "published": "2023-12-29T12:09:00Z",
    "title": "El SEPE publica ofertas de empleo indefinido para personal de limpieza: sueldo de 1.800 euros",
    "text": "El SEPE publica ofertas de empleo indefinido para personal de limpieza: sueldo de 1.800 euros\nEl Servicio Público de Empleo Estatal (SEPE) cuenta en su página laboral ‘Empléate’ con 700 ofertas de trabajo activas para personal de limpieza. Con contrato indefinido, sin experiencia previa ni estudios, todas ellas cuentan con el plazo de solicitud abierto para enviar el currículum. Repartidas por toda España, se buscan profesionales para trabajar limpiando oficinas, centros educativos, cristales y otras instalaciones como casas particulares.\nAunque los sueldos que se paga a los profesionales del sector de la limpieza son variados, cambiando en función de la jornada, o pagando por horas sueltas, se pueden poner algunos ejemplos. El salario para un técnico de limpieza en Girona comienza por los 1.300 euros, pero podrá tener una progresión salarial hasta los 1.800 euros. Esto es lo que señala la vacante publicada por la empresa. Pero esto cambia dependiendo de dónde se quiera postular. La jornada laboral, los horarios, los turnos y las funciones serán explicadas durante la entrevista de trabajo.\nAlgunas de estas ofertas de empleo indefinido son específicas para personas con discapacidad, que tendrán que acreditar con un certificado que es de un 33% o superior.\nEmpleo para personal de limpieza con contrato indefinido Las ofertas de empleo publicadas por el Servicio Público de Empleo Estatal a las que enviar el currículum, ya se pueden consultar en ‘Empléate’. Algunas de ellas son:\nServicio de limpieza para la empresa Supera SL en Córdoba. Contrato de interinidad, jornada completa. De lunes a domingo con los descansos que corresponden según convenio. Se pide certificado de discapacidad y se valora la experiencia y tener vehículo propio. Limpieza y friegue en Valencia. Jornada completa, para cubrir descansos y vacaciones de compañeros en varios restaurantes. Sueldo 1.300 euros. 4 operarios de limpieza en Madrid con discapacidad. Sueldo de 1.080 euros al mes en 14 pagas, horario de lunes a domingo, jornada de entre 2 y 5 horas al día. Limpieza en una platería en Tenerife. Se valorará experiencia previa a partir de 12 meses, 40 horas a la semana. Turnos rotativos. 2 operarios de limpieza para la empresa Clean J&C en Barcelona. Para limpiar cristales, oficinas y obras. Horarios cambiantes, buen ambiente. Personal de limpieza en las Islas Baleares, 4 horas al día de 8:00 a 12:00, con vehículo propio y documentación en regla para trabajar. 14 pagas más vacaciones. Personal masculino de limpieza para trabajar en la limpieza de un gimnasio. Sueldo de hasta 15.000 euros con experiencia valorable de más de 6 meses. 2 limpiadores para trabajar en tiendas del Centro Comercial La Roca Village en Barcelona. Contrato de 15 horas a la semana, de lunes a domingo con un día de descanso. Horario antes de la apertura. 3 técnicos de limpieza en La Cerdanya (Girona), jornada completa, formación gratuita y continua a cargo de la empresa, horario de lunes a viernes. Sueldo de 15.600 a 22.000 euros. Horario de 8:30 a 16:30. Cómo solicitar un empleo en limpieza publicado por el SEPE Para apuntarse a las ofertas de trabajo publicadas por el SEPE hay que entrar en el portal laboral ‘Empléate’. Nada más acceder a la página del Ministerio de Trabajo y Economía Social, aparece un buscador en la parte superior donde poner ‘limpieza’. Dándole a buscar se abren todas las ofertas de trabajo disponibles.\nSolicitar una de ellas es sencillo. Basta con pinchar sobre el nombre de la vacante para que se abra una nueva pestaña con todas las condiciones laborales. Una vez ahí hay que dar a ‘Inscribirse’. Hará falta estar dado de alta en la página para poder enviar la solicitud.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Labor",
      "Economy, Business and Finance"
    ],
    "external_links": [
      "https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1mc5oC.img",
      "https://www.img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1mc5oC.img"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2023-12-29T14:17:57.771+02:00",
    "updated": "2023-12-29T14:17:57.771+02:00"
  },
  {
    "uuid": "dff2b18b577d61b5af688fd86cee2a3582600ba7",
    "url": "https://www.postregister.com/businessreport/government/biocryst-announces-preliminary-full-year-2023-orladeyo-berotralstat-net-revenue-of-325/article_27f30241-5a20-541e-a161-b204350938ec.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "BioCryst Pharmaceuticals, Inc. - (GLOBE NEWSWIRE)",
    "published": "2024-01-05T19:03:00Z",
    "title": "BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 ... | Government | postregister.com",
    "text": "—ORLADEYO preliminary 2023 full year net revenue of $325 million (+29 percent y-o-y)—\n—ORLADEYO net revenue expected to be between $380-$400 million in 2024, on trajectory for\n$1 billion in peak sales—\n—Operating expenses expected to remain flat ($365-$375 million) in 2024—\n—Company expects operating profit in 2024, approaching positive EPS and positive cash flow in 2H 2025—\nRESEARCH TRIANGLE PARK, N.C., Jan. 05, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced preliminary, unaudited ORLADEYO® (berotralstat) net revenue for the fourth quarter and full year 2023. The company also provided guidance for full year 2024 ORLADEYO net revenue, full year 2024 operating expenses, expected peak ORLADEYO sales and an accelerated path to profitability.\n“After three years on the market, ORLADEYO continues on a steady growth trajectory to achieve $1 billion at peak. This commercial success, alongside our proven discovery platform that is producing additional first-in-class or best-in-class molecules, uniquely positions BioCryst to achieve financial independence from the capital markets and accelerate our path to profitability,” said Jon Stonehouse, president and chief executive officer of BioCryst.\nThe company also announced that, if its ongoing proof-of-concept trial produces best-in-class data, it plans to out-license late-stage development and commercialization of BCX10013, its potential once-daily, oral Factor D inhibitor, to a partner that can drive the speed and breadth of investment required to accelerate BCX10013 for patients across multiple complement-mediated diseases and maximize the commercial potential of the program. As a result, the company has reduced the size of its R&D organization and accelerated its timeline to profitability.\nPreliminary Fourth Quarter and Full Year 2023 ORLADEYO Revenue and 2024 ORLADEYO Outlook\nPreliminary, unaudited ORLADEYO net revenue in the fourth quarter of 2023 was $89.9 million (+27 percent y-o-y). Preliminary, unaudited ORLADEYO net revenue for full year 2023 was $325 million (+29 percent y-o-y).\nThe company expects full year 2024 global net ORLADEYO revenue to be between $380 million and $400 million. The general pattern of revenue throughout 2024 is expected to be similar to past years, with the seasonal impact of prescription reauthorizations and the potential impact of the Inflation Reduction Act in the first quarter driving a quarter-over-quarter revenue decline in the first quarter, followed by a strong return to growth in the second quarter.\n“ORLADEYO growth remained strong in the fourth quarter of 2023 as hereditary angioedema patients gain the excellent attack control they expect. Comparing U.S. patient trends year over year (y-o-y), we had more new patient prescriptions and a lower average rate of monthly discontinuations in 2023 compared to 2022. U.S. performance combined with continued global expansion keep ORLADEYO on track for $1 billion in peak sales,” said Charlie Gayer, chief commercial officer of BioCryst.\nOperating Expense and Profitability Outlook\nThe company expects full year 2024 operating expenses to be between $365 million and $375 million, flat to expected full year 2023 operating expenses. The company now expects that R&D expenses in 2024 will be reduced by $20 million versus 2023. This represents a $45 million to $55 million reduction from the 2024 R&D expense guidance it provided at its R&D Day in November 2023, and reflects both the R&D restructuring and the postponement of previously planned capital expenditures at its Discovery Center in Alabama. SG&A expenses are expected to increase by $20 million in 2024, primarily to support the continued U.S. and global growth of ORLADEYO to $1 billion in peak sales.\nThis operating expense outlook does not reflect non-cash stock compensation expense, or one-time expenses related to the reduction of 59 jobs (10 percent of total organization) in the first quarter of 2024.\nBased on the company’s disciplined approach to capital allocation, and the revenue expected from ORLADEYO, the company expects to achieve a full-year operating profit in 2024 (not including non-cash stock compensation), be approaching quarterly positive earnings per share (EPS) and positive cash flow in the second half of 2025 (not including non-cash stock compensation), and be profitable on an EPS basis, with positive cash flow, for full year 2026. The company expects it can achieve these financial milestones without raising additional funds and does not intend to draw the additional $150 million of debt available to it from Pharmakon.\nPresentation Tuesday at 42nd Annual J.P. Morgan Healthcare Conference\nOn Tuesday, January 9, 2024 at 6:00 p.m. ET, the company will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. Links to a live audio webcast and replay of the presentation may be accessed in the Investors section of BioCryst’s website at https://www.biocryst.com/ .\nAbout BioCryst Pharmaceuticals\nBioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn .\nForward-Looking Statements\nThis press release contains forward-looking statements, including statements regarding preliminary, unaudited net revenue results and future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause BioCryst’s actual results, performance or achievements to be materially different from any preliminary, unaudited net revenue results and future results, performance or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: BioCryst’s completion of its customary closing, review and audit procedures for the fourth quarter and full year 2023, which may cause actual net revenue results for these periods to differ materially from the preliminary, unaudited revenue results; the ongoing COVID-19 pandemic, which could create challenges in all aspects of BioCryst’s business, including without limitation delays, stoppages, difficulties and increased expenses with respect to BioCryst’s and its partners’ development, regulatory processes and supply chains, negatively impact BioCryst’s ability to access the capital or credit markets to finance its operations, or have the effect of heightening many of the risks described below or in the documents BioCryst files periodically with the Securities and Exchange Commission; BioCryst’s ability to successfully implement its commercialization plans for, and to commercialize, ORLADEYO, which could take longer or be more expensive than planned; BioCryst’s ability to successfully implement its plans for BCX10013, including any out-licensing of late-stage development and commercialization of BCX10013 as described herein; risks related to the reduction in size of BioCryst’s R&D organization; the results of BioCryst’s partnerships with third parties may not meet BioCryst’s current expectations; risks related to government actions, including that decisions and other actions, including as they relate to pricing, may not be taken when expected or at all, or that the outcomes of such decisions and other actions may not be in line with BioCryst’s current expectations; the commercial viability of ORLADEYO, including its ability to achieve market acceptance; the FDA or other applicable regulatory agency may require additional studies beyond the studies planned for products and product candidates, may not provide regulatory clearances which may result in delay of planned clinical trials, may impose certain restrictions, warnings, or other requirements on products and product candidates, may impose a clinical hold with respect to product candidates, or may withhold, delay or withdraw market approval for products and product candidates; BioCryst’s ability to successfully manage its growth and compete effectively; risks related to the international expansion of BioCryst’s business; timing for achieving profitability and positive cash flow may not meet management’s expectations; statements and projections regarding financial guidance and goals and the attainment of such goals may differ from actual results based on market factors and BioCryst’s ability to execute its operational and budget plans; and actual financial results may not be consistent with expectations, including that revenue, operating expenses and cash usage may not be within management's expected ranges. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, which identify important factors that could cause actual results to differ materially from those contained in BioCryst’s projections and forward-looking statements.\nBCRXW\nContact:\nJohn Bluth\n+1 919 859 7910\njbluth@biocryst.com\nCopyright 2024 GlobeNewswire, Inc.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology",
      "Economy, Business and Finance"
    ],
    "external_links": [
      "https://www.globenewswire.com/Tracker?data=YOgNbb7372Apkp6dFoO2pLDm1zL3279b81HXoyWU3pYtrCmdC7yziakrsi9-lGFMUEsFsy-SuIlG5yJM3IJ0YpTx_JC5Q8lC1M-L0dp_G0c=",
      "https://www.biocryst.com/",
      "https://www.globenewswire.com/Tracker?data=czWxyXvyjEjwoHYFk5hHVVIRU25U-gU4Mkb05B2OuZaU7YRxDlrkZAqnJ6oW4ds7TQJjKnxo6qqM_r8sftaQrV6OEI_SE3-fx2X1RPMwReo=",
      "https://www.globenewswire.com/Tracker?data=dwQGBHOX6GtgngMwNETVmN3c83zngUP_cZFP04nfYqjYQPfyHMc7qwG2MUYPhxRxzvPRwNq9j6zGOZ_v40SnkZ-BLcZj-xNa0rwvUvUk4scm7R21yQWX6pV-CMNuf0kC",
      "https://www.globenewswire.com/Tracker?data=Ou1GL6oWLBMK5sIn1Yi4zII5Fgwm2dbnte0txxNc-bUT-KTs3S9kb2YF9Cy_rsJwd-U9CWDadaqZblk2KaHb09G0LZsSa_ra46cLc1J9rjI=",
      "https://www.globenewswire.com/Tracker?data=z8Gk0YjDYM8mtke-j5Qa5XbUC_alCEmKhzz0H_IwSzNmzmj5H7OMHxHFPFL0jLbr0PCTPY6Z92rb-O2PMr4-aw==",
      "https://biocryst.com/",
      "https://globenewswire.com/Tracker?data=Ou1GL6oWLBMK5sIn1Yi4zII5Fgwm2dbnte0txxNc-bUT-KTs3S9kb2YF9Cy_rsJwd-U9CWDadaqZblk2KaHb09G0LZsSa_ra46cLc1J9rjI=",
      "https://globenewswire.com/Tracker?data=z8Gk0YjDYM8mtke-j5Qa5XbUC_alCEmKhzz0H_IwSzNmzmj5H7OMHxHFPFL0jLbr0PCTPY6Z92rb-O2PMr4-aw==",
      "https://globenewswire.com/Tracker?data=dwQGBHOX6GtgngMwNETVmN3c83zngUP_cZFP04nfYqjYQPfyHMc7qwG2MUYPhxRxzvPRwNq9j6zGOZ_v40SnkZ-BLcZj-xNa0rwvUvUk4scm7R21yQWX6pV-CMNuf0kC",
      "https://globenewswire.com/Tracker?data=YOgNbb7372Apkp6dFoO2pLDm1zL3279b81HXoyWU3pYtrCmdC7yziakrsi9-lGFMUEsFsy-SuIlG5yJM3IJ0YpTx_JC5Q8lC1M-L0dp_G0c=",
      "https://www.globenewswire.com/Tracker",
      "https://globenewswire.com/Tracker?data=czWxyXvyjEjwoHYFk5hHVVIRU25U-gU4Mkb05B2OuZaU7YRxDlrkZAqnJ6oW4ds7TQJjKnxo6qqM_r8sftaQrV6OEI_SE3-fx2X1RPMwReo=",
      "https://www.biocryst.com"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "biocryst",
          "sentiment": "neutral"
        },
        {
          "name": "biocryst pharmaceuticals, inc.",
          "sentiment": "none"
        },
        {
          "name": "orladeyo",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "triangle park",
          "sentiment": "none"
        },
        {
          "name": "n.c.",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-01-06T00:41:04.551+02:00",
    "updated": "2024-01-06T00:41:04.551+02:00"
  },
  {
    "uuid": "a7e7649dd93316ecfcc98a15472f9c54a205d5c4",
    "url": "https://finance.eastmoney.com/a/202504173379099694.html",
    "ord_in_thread": 0,
    "author": "中国证券报",
    "published": "2025-04-16T21:07:00Z",
    "title": "新场景新产品新服务 消费主引擎增添\"新\"动力 _ 东方财富网",
    "text": "一季度中国经济“成绩单”出炉，经济运行起步平稳开局良好，高质量发展呈现向新向好的蓬勃态势。本报今起推出“首季中国经济观察”系列报道，通过多维视角，探寻中国经济在稳增长、促转型、增动能中展现出的韧性与活力。\n　　 线上线下 ，家电、数码产品销售喜报频传，车市月度增速刷新近十年纪录；多地景区，外骨骼 机器人 开启试用，“赛博爬山”解锁文旅消费新体验；消博会上，智能 机器人 、 智能家居 、 智能穿戴 产品等众多智能产品闪耀亮相，加快从实验室走入“百姓家”……\n　　一季度，我国大宗消费增势稳健，部分商品表现超出预期；服务消费方兴未艾，增长速度超过商品消费；新型消费蓬勃发展，前沿科技赋能消费场景创新。\n　　专家表示，消费是拉动经济增长的主引擎。提振消费具有重要现实作用和长远意义。当前，政策持续发力，“以旧换新”加力扩围、扩大服务消费等举措加快落地显效；科技赋能推动智能产品、服务场景创新扩容；服务消费占比提升，文体旅融合深化，成为增长新动能。未来需进一步优化收入分配、完善社会保障，以消费升级夯实经济高质量发展根基。\n　　 “新”意渐浓\n　　 商品消费提质向好\n　　打开 京东 App，补贴专区格外醒目，国家补贴、平台补贴等各式优惠一目了然，“出口转内销”会场好物琳琅满目。走进西单 大悦城 ，草莓熊、史迪奇的公仔在52TOYS“莓好奇遇”快闪店的全国首站中分外吸睛，为这家已运营18年的商场引来更多客流。\n　　消费向好的态势不止在“眼”前，也在“数”里行间。国家统计局16日公布，一季度，社会消费品零售总额增长4.6%，增速逐月回升。其中，3月消费增速达5.9%，创13个月新高。\n　　商品消费在我国消费中占大头。“以旧换新”政策加力扩围、消费金融组合出招、地方政府连环施策……\n　　2025年以来，政策创新蔚然成风，聚焦提振消费接续用力、更加给力。\n　　汽车作为传统大宗消费品，是推动消费增长的重要力量。中汽协数据显示，一季度，我国汽车产销量分别为756.1万辆和747万辆，同比分别增长14.5%和11.2%。3月，乘用车销量246.8万辆，同比增长10.4%，增速为近十年同期最高。中汽协副秘书长陈士华分析，一系列提振汽车消费政策措施得以延续并加速落地，推动汽车产销呈现两位数增长，实现良好开局，相关政策组合效应将持续释放，有助于延续市场增长态势。\n　　IP经济、 首发经济 为传统商圈增添品牌力与吸引力。“西单 大悦城 今年已推出三个全国级首发首展。接下来，我们将继续接洽高品质的首发资源。”西单 大悦城 相关工作人员告诉中国 证券 报记者。\n　　第五届消博会首设新消费科技展区，智能 机器人 、全屋 智能家居 、 智能穿戴 产品等智能产品集中亮相；4月19日，全球首个 人形机器人 半程马拉松将在北京亦庄开跑；近期， 优必选 与 居然智家 签订战略合作协议，拟推动智能养老机器人在家庭服务环境及相关养老服务场景的应用……从展台、赛道到家庭，智能消费正加速融入日常生活。\n　　“促进 人工智能 消费终端进千家万户， 人工智能 商业终端进千商万店， 人工智能 技术赋能消费场景创新。”商务部市场运行和消费促进司司长李刚说。\n　　 方兴未艾\n　　 服务消费加快发展\n　　科技与政策的共同驱动下，商品消费焕新升级、展现活力，服务消费也加快发展、释放潜能，成为消费扩容升级的重要抓手。\n　　中国旅游研究院研究员韩元军表示，一季度，在春节假期、冰雪季等因素助推下，我国文旅市场进入繁荣发展新周期。游客出行意愿、旅游市场整体规模、以上市公司为代表的企业营收等多维度指标均达到历年的新高度。“供给侧创新，是驱动文旅消费快速增长的重要因素之一。”韩元军说。\n　　高科技产品服务与景区特色“一拍即合”，解锁更多消费新场景，驱动文旅消费进一步升级。“近年来，公司抢抓人工智能发展浪潮，研发打造黄山AI旅行助手，并在今年2月全面接入DeepSeek大模型，推动其在智能交互、场景服务、伴游体验等方面的全面升级。” 黄山旅游 相关负责人告诉记者。\n　　随着“健康中国”战略深入实施，体育经济发展势头正酣，“体育+文旅”也成为消费市场的重要增长点。\n　　“体育消费作为 体育产业 的内驱力，在促进经济增长、扩大内需等方面的作用日益凸显。”北京师范大学体育与运动学院副院长王兆红表示，一方面，体育消费直接带动体育用品制造、赛事运营、体育健身服务、体育旅游、体育培训等体育相关产业发展；另一方面，体育消费能够突破行业界限，衍生出“体育+文旅”“体育+康养”等产业协同联动的经济新业态，展现显著的乘数效应和区域经济带动作用。\n　　文旅出行、体育健康、住宿餐饮、养老育幼……从更大范围看，服务消费正多点开花。\n　　“从历史经验来看，服务业发展对提振消费意义重大。从需求端促进服务消费，从供给端支持服务业，可能是接下来经济政策的重要发力方向。” 京东 集团首席经济学家沈建光说。\n　　服务消费将迎来更多政策支持。商务部部长王文涛表示，将多措并举扩大服务消费，加快政策推出，出台支持家政服务消费、发展数字消费等政策文件，会同相关部门制定促进旅游业、超高清、体育赛事经济、中医药健康发展等支持政策。\n　　 促进增收\n　　 夯实消费增长之基\n　　外部环境变化，使扩大内需的必要性、提高居民消费能力和水平的必要性进一步上升。\n　　消费是收入的函数，要提振消费，需促进消费能力提升。“在其他因素不变的情况下，居民收入增长越快、居民财富增长越快、居民对未来的预期越乐观，居民消费增长越快。”中国社会科学院金融研究所副所长、国家金融与发展实验室副主任张明说。\n　　在中国人民大学中国就业研究所研究员毛宇飞看来，当居民收入提高后，可支配收入增多，直接提升了购买力。同时，稳定的收入增长也带来了稳定的租金、利息等财产性收入增加，会提升居民的预期、增强消费信心，促使他们敢于消费，进而对当期和未来消费支出带来积极影响。\n　　张明建议，从收入维度提振居民消费，应通过财政补贴的方式增加中低收入家庭短期收入，大力促进民营企业的发展以进一步解决就业问题。同时，在国民收入跨部门分配方面，应显著提高居民部门收入所占份额；在居民部门内部，应逐渐实施更具力度的收入再分配政策，以增加中低收入群体收入占比。\n　　从改善预期的角度看，毛宇飞建议，一方面要稳定预期，通过积极完善医疗、养老、失业等社会保障制度，减轻居民对未来不确定性的担忧；另一方面，要提高人力资本，这不仅可以提高劳动力素质，增加收入水平和生产效率，还能进一步改善消费结构、促进消费升级。\n　　“为了同时促进短期经济复苏与中长期经济增长，应该更加鼓励有助于培育人力资本的消费。”张明说。\n　　消费是驱动经济增长的引擎，超大规模国内市场构成抵御外部冲击的底气。可以期待，当政策工具箱精准激活要素潜能，当数字技术深度重构消费生态，当民生改善持续夯实消费基底，消费引擎将持续驱动中国经济巨轮劈波斩浪、勇毅前行。\n（文章来源：中国 证券 报）",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "positive",
    "categories": [
      "Economy, Business and Finance",
      "Social Issue",
      "Politics"
    ],
    "topics": [
      "Economy, Business and Finance->financial and economic news",
      "Economy, Business and Finance->economy",
      "Social Issue->demographics",
      "Social Issue->population and census",
      "Social Issue->social condition",
      "Politics->economic policy"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-17T00:25:42.420+03:00",
    "updated": "2025-04-17T00:25:42.420+03:00"
  },
  {
    "uuid": "ef2c6ae2278a4ffe7926390347e7ebf5452eeaaf",
    "url": "https://www.amny.com/news/nyc-snowless-streak-ends-701-days/",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Robert Pozarycki",
    "published": "2024-01-16T13:54:00Z",
    "title": "SNOWLESS STREAK OVER! NYC finally sees a legitimate snowfall after 701 days",
    "text": "Central Park recorded an inch of snow on the ground early Tuesday morning, snapping the longest snowless streak in New York City’s history at 701 days.\nMore snow is expected to fall across the city Tuesday as a result of the weather system that started dumping the white stuff across the five boroughs Monday night. A winter weather advisory remains in effect through 7 p.m. Jan. 16.\nForecasters estimate total accumulation in the city will be 2 to 4 inches of snow by the time the flakes start falling. As of 7:22 a.m. Jan. 16, the National Weather Service reported 1.4 inches of snow on the ground in Central Park.\nIt had been nearly two years since New York City saw a snowfall of at least one inch; the most recent occurrence was in February 2022 . It was the longest snowless streak since weather record-keeping began in 1869.\nTuesday’s snowfall, however, may not be a cause of rejoicing for commuters trying to get to work or school today. New Yorkers are reminded to allow for extra travel time while traversing the snow-slick streets, and to take public transit wherever possible.\nSo far, the MTA has reported few weather-related delays on the subways and buses. Visit MTA.info for the latest information.\nFor the first time in 701 days, New Yorkers got a chance to make snowballs after the snowless streak was snapped Tuesday. Photo by Dean Moses Commuters wait in Manhattan for a bus on Jan. 16, 2024, the first snowy morning in nearly two years. Photo by Dean Moses The first snowstorm of 2024 made for a messy morning commute. New Yorkers should allow themselves extra travel time while walking the snow-slick streets. Photo by Dean Moses\nThe Sanitation Department has been out in full force with its fleet of nearly 800 salt spreaders to keep the roadways as clear as possible, and prevent icing. As of 6:30 a.m. Tuesday, the agency reported spreading 40 million pounds of salt on the streets, with more to come Tuesday.\nTrash and recycling collections, however, remain on Tuesday — so don’t forget to place your waste at the curb if you’re scheduled for a pickup.\nNew Yorkers should allow themselves extra travel time while walking the snow-slick streets. Photo by Dean Moses An NYPD officer stands post on a snow-slick Manhattan street on Jan. 16, 2024. Photo by Dean Moses Some New Yorkers resorted to snowblowers to clear their sidewalks Photo by Dean Moses For the first time in a long time, New Yorkers are shoveling snow as a 701-day snowless streak came to an end on Jan. 16, 2024. Photo by Dean Moses\nNew Yorkers, meanwhile, have begun the arduous process of clearing snow from the sidewalks in front of their homes, offices and businesses — something required by law.\n“Sidewalks should be passable for all pedestrians, including a minimum 4-foot clear path, where possible,” the city’s Emergency Management department noted on X (the platform formerly known as Twitter). “While property owners are not required to clear bus stops, @NYCSanitation suggests that property owners clear a path from the sidewalk to the curb at the bus stop.”\nIf the final flakes fall before 5 p.m. Tuesday, property owners have until four 4 hours after the snow ended to clear their sidewalks. Anyone who fails to comply risks a fine starting at between $100 and $150.\nMoreover, the Emergency Management department reminds New Yorkers not to shovel snow into the street, as it impedes Sanitation Department efforts to keep the roads clear.\nThe National Weather Services says the snow may briefly change over to light rain before changing back to an icy mix and/or snow before finally clearing out Tuesday afternoon. Then New York will experience a frigid rest of the week, with temperatures not expected to break the freezing point through at least Friday, when the city could experience more snow.\nIf the snow stops falling between:\n•7 a.m. and 5 p.m., property owners must clear sidewalks within 4 hours\n•5 p.m. and 9 p.m., property owners must clear sidewalks within 14 hours\n•9 p.m. and 7 a.m., property owners must clear sidewalks by 11 a.m.\n— NYC Emergency Management (@nycemergencymgt) January 16, 2024\n ",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Human Interest",
      "Weather"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "national weather service",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "new york city",
          "sentiment": "none"
        },
        {
          "name": "central park",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-01-16T15:54:23.851+02:00",
    "updated": "2024-01-16T15:54:23.851+02:00"
  },
  {
    "uuid": "dc19cafda78f80f16f33e37be977b8ca1dadf680",
    "url": "https://www.lefigaro.fr/actualite-france/bretagne-un-trafic-de-fentanyl-demantele-trois-personnes-mises-en-examen-20240613",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "lefigaro.fr",
    "published": "2024-06-13T20:34:00Z",
    "title": "Un trafic de Fentanyl démantelé en Bretagne, trois personnes mises en examen",
    "text": "Un trafic de Fentanyl démantelé en Bretagne, trois personnes mises en examen Par Le Figaro avec AFP Publié il y a 4 minutes , Mis à jour à l’instant Lire dans l’app Copier le lien Lien copié Mail Facebook Twitter Linkedin Messenger WhatsApp Une opération menée lundi par plus d'une centaine de gendarmes de l'OCLAESP et de la région Bretagne a abouti au placement en garde à vue de 15 personnes, principalement à Rennes. Xose Bouzas / Xose Bouzas / Hans Lucas via Reu La Juridiction interrégionale spécialisée (JIRS) dans le crime organisé de Rennes a identifié 723 ordonnances ayant permis la délivrance de 2.300 boîtes de Fentanyl dans 17 départements de l'ouest de la France.\nTrois personnes ont été mises en examen jeudi 13 juin par un juge d'instruction à Rennes après le démantèlement d'un réseau d'obtention illicite d'un médicament puissamment addictif, le Fentanyl , a-t-on appris auprès du parquet. Il s'agit de deux hommes et une femme, âgés de 26 à 44 ans et de nationalité géorgienne, indique dans un communiqué le procureur de la République de Rennes, Philippe Astruc, confirmant l'information sur ce trafic révélée par Le Parisien . «De nationalité géorgienne, âgés de 26 à 44 ans, ils résident dans des logements sociaux à Rennes et sont fortement dépendants au Fentanyl. Ils ne présentent pas d'antécédents judiciaires notables, bien que l'un avait été condamné à deux reprises pour des faux et usages de faux en écriture en 2022 et 2024» , précise-t-il. Les deux hommes ont été placés en détention provisoire et la femme a été placée sous contrôle judiciaire.\nL'affaire avait débuté en mai 2023 lorsque le commissariat de police de La Baule (Loire-Atlantique) interpellait en flagrant délit un Géorgien qui présentait à plusieurs pharmacies locales des ordonnances volées et/ou falsifiées, pour obtenir la délivrance de médicaments contenant du Fentanyl dans sa posologie maximale, notamment sous forme de patchs transdermiques. Le Fentanyl est un analgésique opioïde ayant un effet environ cent fois plus puissant que la morphine et au moins cinquante fois plus que l'héroïne, extrêmement addictif (dépendance physique et psychique), souligne le parquet de Rennes dans son communiqué.\nConsommation personnelle et revente Après la mise en examen et en détention du mis en cause, les investigations menées par l'antenne rennaise de l'Office central de lutte contre les atteintes à l'environnement et à la santé publique (OCLAESP) démontraient l'existence d'un «groupe criminel» actif depuis plusieurs années «dans l'ensemble des départements du Grand-Ouest» . La Juridiction interrégionale spécialisée (JIRS) dans le crime organisé de Rennes a identifié au total 723 ordonnances (517 falsifiées et 206 issues de vols) ayant permis la délivrance de 2.300 boîtes de Fentanyl dans 17 départements de l'ouest de la France. «À ce stade, il est établi que le Fentanyl est destiné pour partie à la consommation personnelle des mis en cause» et pour partie à la revente au sein de la communauté géorgienne en France, selon le communiqué du parquet.\nUne opération menée lundi 10 juin par plus d'une centaine de gendarmes de l'OCLAESP et de la région Bretagne avait abouti au placement en garde à vue de 15 personnes, principalement à Rennes. Deux d'entre elles ont été mises hors de cause, victimes d'une usurpation d'identité. Dix autres ont été remises en liberté, car identifiées comme étant de simples clientes du réseau ou pour poursuite des investigations.\nContrairement à la France où le produit mis en cause est un médicament contrôlé par les autorités, aux États-Unis - où cet opioïde et ses dérivés sont devenus un important problème de santé publique -, «la consommation de Fentanyl ne porte pas sur les médicaments mais sur une drogue de synthèse importée par les cartels mexicains ou venant de Chine» , a souligné Philippe Astruc.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Crime, Law and Justice"
    ],
    "webz_reporter": false,
    "external_links": [
      "https://sfgs.adj.st/resource?url=https://www.lefigaro.fr/actualite-france/bretagne-un-trafic-de-fentanyl-demantele-trois-personnes-mises-en-examen-20240613&adj_t=17w3s48x&adj_campaign=acquiz-web-article-news",
      "https://sfgs.adj.st/resource?url=https://lefigaro.fr/actualite-france/bretagne-un-trafic-de-fentanyl-demantele-trois-personnes-mises-en-examen-20240613&adj_t=17w3s48x&adj_campaign=acquiz-web-article-news",
      "https://sfgs.adj.st/resource"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-06-14T00:47:36.469+03:00",
    "updated": "2024-06-14T00:47:36.469+03:00"
  }
]